Drug Standards
Enzo Life Sciences Minoxidil-sulfate (25mg). CAS: 83701-22-8
A selective ATP-sensitive K+ (KATP) channel opener. It is the active metabolite of minoxidil (BML-KC125) and is a potent (IC50=0.14 µM) vascular smooth muscle relaxant. Antihypertensive. Stimulates renin secretion. Alternative name: U-58838. Purity: ≥98%. Solubility: Soluble in DMSO (25mg/ml). Long Term Storage: Ambient.
Perkin Elmer US LLC Pharmaceutical OVI Application Consumables Kit
Kit includes: Elite-1301 30 M x 0.53 mm x 3.0µm column, Zero Dilution Glass Outer Liner, Zero Dilution Glass Inner Liner, Polyimide uncoated deactivated tubing, 5 M x 0.18 mm, 22 mL headspace vials, 19 mm assembled cap and septa PTFE/silicone and 20 mm electronic crimper (120V).
Cayman Chemical Isosorbide dinitrate 50MG
An NO donor; induces vasodilation in isolated precontracted rabbit femoral vein and artery (IC50s = 0.56 and 1.82 µM, respectively); decreases oxygenation of tumor tissue in vivo in mice; inhibits platelet aggregation in vitro and in vivo
Selleck Chemical LLC S-Ruxolitinib (INCB018424) S2902-5mg
S-Ruxolitinib is the chirality of INCB018424 which is the first potent selective JAK1/2 inhibitor to enter the clinic with IC50 of 3 3 nM/2 8 nM 130-fold selectivity for JAK1/2 versus JAK3 Phase 3
Apexbio Technology LLC Norfloxacin hydrochloride 104142-93-0 10mM (in 1mL DMSO)
Norfloxacin hydrochloride is a small-molecule inhibitor targeting bacterial DNA gyrase It is designed to inhibit DNA gyrase an enzyme essential for the supercoiling and replication of bacterial DNA thereby disrupting bacterial DNA synthesis and interfering with bacterial replication and growth Norfloxacin hydrochloride exerts its biological activity primarily through the inhibition of DNA gyrase by binding within the enzyme s active site impeding its catalytic activity Based on these pharmacological properties Norfloxacin hydrochloride holds research potential in the study of bacterial resistance mechanisms bacterial enzyme inhibition assays antimicrobial susceptibility testing and therapeutic research on antibacterial treatment strategies against Gram-positive and Gram-negative bacteria
Sigma Aldrich Fine Chemicals Biosciences Gabapentin Related Compound D United States Pharmacopeia (USP) Reference Standard | 1076198-17-8 | MFCD19705130 | 10MG
Gabapentin Related Compound D United States Pharmacopeia (USP) Reference Standard | Mol Wt: 307.43 | 1076198-17-8 | MFCD19705130 | 10MG
Sigma Aldrich Fine Chemicals Biosciences Doxycycline for system suitability European Pharmacopoeia (EP) Reference Standard | 24390-14-5 | MFCD07357237 |
Doxycycline for system suitability European Pharmacopoeia (EP) Reference Standard | Mol Wt: 512.94 | 24390-14-5 | MFCD07357237 |
Sigma Aldrich Fine Chemicals Biosciences Gabapentin impurity B European Pharmacopoeia (EP) Reference Standard | 133481-09-1 | MFCD04117948 |
Gabapentin impurity B European Pharmacopoeia (EP) Reference Standard | Mol Wt: 167.21 | 133481-09-1 | MFCD04117948 |
Sigma Aldrich Fine Chemicals Biosciences Pioglitazone hydrochloride European Pharmacopoeia (EP) Reference Standard | 112529-15-4 | MFCD04975446 |
Pioglitazone hydrochloride European Pharmacopoeia (EP) Reference Standard | Mol Wt: 392.9 | 112529-15-4 | MFCD04975446 |
Sigma Aldrich Fine Chemicals Biosciences Cisapride United States Pharmacopeia (USP) Reference Standard | 260779-88-2 | MFCD03305346 | 200MG
Cisapride United States Pharmacopeia (USP) Reference Standard | Mol Wt: 483.96 | 260779-88-2 | MFCD03305346 | 200MG
Sigma Aldrich Fine Chemicals Biosciences Ranitidine Related Compound B United States Pharmacopeia (USP) Reference Standard | 72126-78-4 | MFCD01727377 | 50MG
Ranitidine Related Compound B United States Pharmacopeia (USP) Reference Standard | Mol Wt: 497.67 | 72126-78-4 | MFCD01727377 | 50MG
Sigma Aldrich Fine Chemicals Biosciences Amisulpride for system suitability European Pharmacopoeia (EP) Reference Standard | 71675-85-9 | MFCD00866691
Amisulpride for system suitability European Pharmacopoeia (EP) Reference Standard | Purity: | MW: 369.48 | 71675-85-9 | MFCD00866691
Sigma Aldrich Fine Chemicals Biosciences Ofloxacin Related Compound A United States Pharmacopeia (USP) Reference Standard | 82419-52-1 | MFCD00871868 | 25MG
Ofloxacin Related Compound A United States Pharmacopeia (USP) Reference Standard | Mol Wt: 347.34 | 82419-52-1 | MFCD00871868 | 25MG
Sigma Aldrich Fine Chemicals Biosciences Rizatriptan benzoate United States Pharmacopeia (USP) Reference Standard | 145202-66-0 | MFCD00866224 | 200MG
Rizatriptan benzoate United States Pharmacopeia (USP) Reference Standard | Mol Wt: 391.47 | 145202-66-0 | MFCD00866224 | 200MG
Sigma Aldrich Fine Chemicals Biosciences Imiquimod >=98% (HPLC), solid | 99011-02-6 | MFCD00866946 | 200MG
Imiquimod >=98% (HPLC), solid | Purity: >=98% (HPLC) | Mol Wt: 240.3 | 99011-02-6 | MFCD00866946 | 200MG